GlassScriptPhysician profile
S D Moss
NPI 1750342861
$343.83
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.80 · 2020: $48.55 · 2021: $199.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $174.79 | 2019-2021 | |
| Piramal Critical Care | $58.33 | 2019-2021 | |
| Baxter Healthcare | $26.66 | 2019 | |
| Greenwich Biosciences, INC. | $20.50 | 2021 | |
| Eisai INC. | $19.46 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $17.92 | 2019 | |
| Advanced Respiratory, INC | $14.20 | 2020 | |
| Ucb, INC. | $11.97 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw S Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.